SYNTHESIS & PHARMACOLOGICAL EVAL OF FLAVONES AS ANTI HIV AGENTS
SYNTHESIS & PHARMACOLOGICAL EVAL OF FLAVONES AS ANTI HIV AGENTS
批准号:
6205916
负责人:
KINFE KEN REDDA
金额:
$8.08万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2000-07-31
中文摘要
人类免疫缺陷病毒(HIV)的发现
获得性免疫缺陷综合征(AIDS)的病原体有
导致了巨大的努力,以揭开病毒的基本行动
分子水平。潜在干预的各种目标
文献中已经概述了艾滋病毒的繁殖。必需品
病毒的繁殖和传播步骤涉及到反向
利用该酶将逆转录病毒RNA转录为前病毒DNA
逆转录酶(RT)。另一个有希望的可能性是
中断病毒生命周期的是使用抑制病毒的
病毒编码的蛋白水解酶,是病毒成熟所必需的。
HIV-1整合酶介导逆转录的整合
病毒DNA进入宿主基因组,是病毒生命周期中必不可少的一步
病毒。HIV整合酶是一种非固有的
代理商发展的东道主和诱人的目标
对抗艾滋病。HIV整合酶已被否定为
相当长的一段时间;最近的事态发展。我们现在建议
多种多羟基杂环芳香族化合物的合成,
有几个具有二级不饱和度,而一个大的
具有类黄酮类结构的品种。已知类黄酮类
槲皮素和咖啡酸苯乙基醚等结构
(CAPE)对肿瘤细胞和HIV具有细胞毒性
病毒。我们现在建议进行研究,以开发
CAPE基化合物AS的构效关系(SAR)数据
HIV整合酶抑制剂。美国国立卫生研究院国家癌症研究所同意
对我们的化合物进行体外抗HIV活性筛选。
英文摘要
The discovery of the human immunodeficiency virus (HIV) as the
causative agent of the acquired immunodeficiency syndrome (AIDS) has
led to enormous efforts to unravel the basic actions of the virus at a
molecular level. A variety of targets for potential intervention of
HIV multiplication have been outlined in the literature. An essential
step for the multiplication and spread of the virus involves reverse
transcription of the retroviral RNA to proviral DNA by the enzyme
reverse transcriptase (RT). Another promising possibility for
interrupting the viral life cycle is the use of inhibitors of the
virally encoded protease which is indispensable for viral maturation.
The HIV-1 integrase enzyme mediates integration of reverse-transcribed
viral DNA into the host genome, an essential step in the life cycle of
the virus. The HIV integrase enzyme which is not indigenous to the
host presents and attractive target for the development of agents
against AIDS. The HIV integrase has been negl ected as a target for
quite a long time until; recent developments. We now propose the
synthesis of many polyhydroxylated heterocyclic aromatic compounds,
with several having secondary degrees of unsaturation and a large
variety bearing a flavonoid structure. It is known that flavonoid
structures, such as quercetin and caffeic acid phenylethyl ether
(CAPE) exhibit cytotoxicity towards tumor cells as well as the HIV
virus. We now propose to undertake studies to develop
structure-activity relationship (SAR) data on CAPE based compounds as
HIV integrase inhibitors. NIH's National Cancer Institute has agreed
to conduct in vitro screening for anti-HIV activity for our compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DRUG DISCOVERY CORE FACILITY (DDCF)
-
批准号:8357111
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2011
-
负责人:KINFE KEN REDDA
-
依托单位:
DRUG DISCOVERY CORE FACILITY (DDCF)
-
批准号:8166144
-
项目类别:
-
资助金额:$58.14万
-
财政年份:2010
-
负责人:KINFE KEN REDDA
-
依托单位:
DRUG DISCOVERY CORE FACILITY (DDCF)
-
批准号:7959136
-
项目类别:
-
资助金额:$61.58万
-
财政年份:2009
-
负责人:KINFE KEN REDDA
-
依托单位:
DDR SUBPROJ 4: SYNTHESIS OF N-AMINOTETRAHYDROPYRIDINES AS ANTICANCER
-
批准号:7715246
-
项目类别:
-
资助金额:$14.67万
-
财政年份:2008
-
负责人:KINFE KEN REDDA
-
依托单位:
DDR SUBPROJ 4: SYNTHESIS OF N-AMINOTETRAHYDROPYRIDINES AS ANTICANCER
-
批准号:7561435
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2007
-
负责人:KINFE KEN REDDA
-
依托单位:
DDR SUBPROJ 4: SYNTHESIS OF N-AMINOTETRAHYDROPYRIDINES AS ANTICANCER
-
批准号:7335958
-
项目类别:
-
资助金额:$10.71万
-
财政年份:2006
-
负责人:KINFE KEN REDDA
-
依托单位:
DDR SUBPROJ 4: SYNTHESIS OF N-AMINOTETRAHYDROPYRIDINES AS ANTICANCER
-
批准号:7164222
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2005
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS: N-AMINOTETRAHYDROPYRIDINES ANTICANCER AGENTS
-
批准号:6981407
-
项目类别:
-
资助金额:$17.29万
-
财政年份:2004
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS & PHARMACOLOGICAL EVAL OF FLAVONES AS ANTI HIV AGENTS
-
批准号:6668386
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS & PHARMACOLOGICAL EVAL OF FLAVONES AS ANTI HIV AGENTS
-
批准号:6651801
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS & PHARMACOLOGICAL EVAL OF FLAVONES AS ANTI HIV AGENTS
-
批准号:6494895
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2001
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS/ ACTIVITY OF N-AMINOTETRAHYDROPYRIDINES
-
批准号:6478810
-
项目类别:
-
资助金额:$3.04万
-
财政年份:2000
-
负责人:KINFE KEN REDDA
-
依托单位:
MBRS/SCORE PROGRAM AT FLORIDA A&M UNIVERSITY
-
批准号:6611361
-
项目类别:
-
资助金额:$154.16万
-
财政年份:2000
-
负责人:KINFE KEN REDDA
-
依托单位:
MBRS/SCORE PROGRAM AT FLORIDA A&M UNIVERSITY
-
批准号:6318105
-
项目类别:
-
资助金额:$157.24万
-
财政年份:2000
-
负责人:KINFE KEN REDDA
-
依托单位:
MBRS/SCORE PROGRAM AT FLORIDA A&M UNIVERSITY
-
批准号:6518778
-
项目类别:
-
资助金额:$143.77万
-
财政年份:2000
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS & PHARMACOLOGICAL EVAL OF FLAVONES AS ANTI HIV AGENTS
-
批准号:6358114
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2000
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME N-AMINOTETRAHYDROPYRIDINES
-
批准号:6338794
-
项目类别:
-
资助金额:$11.1万
-
财政年份:2000
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME N-AMINOTETRAHYDROPYRIDINES
-
批准号:6344861
-
项目类别:
-
资助金额:$3.04万
-
财政年份:2000
-
负责人:KINFE KEN REDDA
-
依托单位:
MBRS/SCORE PROGRAM AT FLORIDA A&M UNIVERSITY
-
批准号:6769699
-
项目类别:
-
资助金额:$24.67万
-
财政年份:2000
-
负责人:KINFE KEN REDDA
-
依托单位:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME N-AMINOTETRAHYDROPYRIDINES
-
批准号:6107165
-
项目类别:
-
资助金额:$11.1万
-
财政年份:1999
-
负责人:KINFE KEN REDDA
-
依托单位:
海外基金